Eposin 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung Bélgica - alemán - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eposin 20 mg/ml konzentrat zur herstellung einer infusionslösung

teva pharma belgium - etoposide - konzentrat zur herstellung einer infusionslösung - 20 mg/ml - etoposide 20 mg/ml - etoposide

Eposin 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung Bélgica - alemán - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eposin 20 mg/ml konzentrat zur herstellung einer infusionslösung

teva pharma belgium - etoposide - konzentrat zur herstellung einer infusionslösung - 20 mg/ml - etoposide 20 mg/ml - etoposide

Zeposia Unión Europea - alemán - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressiva - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.